Moberg Pharma AB (publ) (MOB) — Working Capital to Net Assets Ratio
Moberg Pharma AB (publ) (MOB) has a Working Capital to Net Assets ratio of 33.3% as of December 2025. Working capital of Skr221.74 Million (current assets of Skr237.91 Million minus current liabilities of Skr16.17 Million) is measured against net assets of Skr665.22 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See MOB net asset quality score to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Moberg Pharma AB (publ) Working Capital to Net Assets (2008–2025)
This chart shows how Moberg Pharma AB (publ)'s Working Capital to Net Assets ratio has evolved across 18 annual periods from 2008 to 2025. As of December 2025, the ratio stands at 33.3%, reflecting working capital of Skr221.74 Million against net assets of Skr665.22 Million SEK. Check Moberg Pharma AB (publ) tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Moberg Pharma AB (publ) (2008–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Moberg Pharma AB (publ) from 2008 to 2025, covering 18 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Moberg Pharma AB (publ) (MOB) market capitalisation.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 33.3% | Skr221.74 Million | Skr665.22 Million | Skr237.91 Million | Skr16.17 Million | ▼ -7.9 pp |
| 2024 | 41.3% | Skr283.39 Million | Skr686.82 Million | Skr300.11 Million | Skr16.72 Million | ▲ +33.2 pp |
| 2023 | 8.0% | Skr48.95 Million | Skr610.73 Million | Skr69.49 Million | Skr20.54 Million | ▼ -10.9 pp |
| 2022 | 18.9% | Skr100.97 Million | Skr533.58 Million | Skr127.76 Million | Skr26.79 Million | ▼ -1.6 pp |
| 2021 | 20.5% | Skr89.12 Million | Skr434.05 Million | Skr104.66 Million | Skr15.54 Million | ▼ -1.4 pp |
| 2020 | 21.9% | Skr86.63 Million | Skr395.58 Million | Skr166.81 Million | Skr80.18 Million | ▲ +9.5 pp |
| 2019 | 12.4% | Skr13.12 Million | Skr105.68 Million | Skr43.02 Million | Skr29.90 Million | ▼ -13.8 pp |
| 2018 | 26.2% | Skr155.79 Million | Skr594.02 Million | Skr211.95 Million | Skr56.16 Million | ▼ -2.7 pp |
| 2017 | 28.9% | Skr159.71 Million | Skr552.41 Million | Skr233.40 Million | Skr73.69 Million | ▲ +2.9 pp |
| 2016 | 26.1% | Skr146.33 Million | Skr561.62 Million | Skr220.87 Million | Skr74.54 Million | ▲ +4.9 pp |
| 2015 | 21.1% | Skr74.48 Million | Skr352.82 Million | Skr119.11 Million | Skr44.63 Million | ▼ -0.2 pp |
| 2014 | 21.3% | Skr64.81 Million | Skr303.75 Million | Skr117.44 Million | Skr52.64 Million | ▲ +17.5 pp |
| 2013 | 3.8% | Skr7.63 Million | Skr201.49 Million | Skr59.22 Million | Skr51.59 Million | ▼ -19.2 pp |
| 2012 | 23.0% | Skr41.00 Million | Skr178.23 Million | Skr101.25 Million | Skr60.26 Million | ▼ -76.0 pp |
| 2011 | 99.0% | Skr76.03 Million | Skr76.79 Million | Skr91.70 Million | Skr15.67 Million | ▲ +76.6 pp |
| 2010 | 22.4% | Skr154.29K | Skr687.70K | Skr11.70 Million | Skr11.54 Million | ▼ -76.3 pp |
| 2009 | 98.8% | Skr29.84 Million | Skr30.21 Million | Skr34.63 Million | Skr4.79 Million | ▼ -0.6 pp |
| 2008 | 99.3% | Skr15.13 Million | Skr15.23 Million | Skr21.81 Million | Skr6.68 Million | — |